Alzheimer s & Dementia Translational Research & Clinical Interventions,
Год журнала:
2024,
Номер
10(3)
Опубликована: Июль 1, 2024
Abstract
INTRODUCTION
The
“A/T/N”
(amyloid/tau/neurodegeneration)
framework
provides
a
biological
basis
for
Alzheimer's
disease
(AD)
diagnosis
and
can
encompass
additional
changes
such
as
inflammation
(“I”).
A
spectrum
of
T/N/I
imaging
plasma
biomarkers
was
acquired
in
phase
2
clinical
trial
rasagiline
mild
to
moderate
AD
patients.
We
evaluated
these
understand
biomarker
distributions
relationships
within
this
population.
METHODS
Plasma
pTau‐181,
neurofilament
light
chain
(NfL),
glial
fibrillary
acidic
protein
(GFAP),
other
inflammation‐related
proteins,
measures
including
fluorodeoxyglucose
(FDG)
positron
emission
tomography
(PET),
flortaucipir
PET,
volumetric
magnetic
resonance
(MRI),
cognitive
endpoints
were
analyzed
assess
characteristics
the
overall
population
(
N
=
47
at
baseline
21
longitudinal
comparisons)
age‐decade
subgroups
(57‐69,
70‐79,
80‐90
years).
RESULTS
Data
demonstrate
wide
heterogeneity
influenced
by
age
sex.
pTau‐181
GFAP
correlate
with
tau
most
strongly
left
inferior
temporal
cortex
p
0.0002,
0.0006,
respectively).
In
regions
beyond
cortex,
PET
uptake
decreased
same
or
concentrations.
FDG
brain
volumes
numerous
(such
temporal:
0.0007,
0.00001,
NfL,
GFAP,
all
modalities
MMSE;
subsequent
MMSE
decline
is
predicted
parahippocampal
lateral
0.0007)
volume
0.0006).
Lateral
0.006)
0.0001)
are
associated
ADAS‐cog
decline.
NfL
correlates
but
not
PET.
Inflammation
intercorrelated
correlated
only
youngest
group.
DISCUSSION
Associations
between
biomarkers,
status
observed
study
provide
insight
into
among
processes
AD.
Findings
show
potential
characterize
patients
regarding
likely
pathology,
neurodegeneration,
prospective
decline,
importance
covariates
age.
Highlights
regional
global
Volume
showed
strong
one
another,
status.
Temporal
both
ADAS‐cog.
enrich
elevated
significant
covariate.
Biomolecules,
Год журнала:
2022,
Номер
12(3), С. 371 - 371
Опубликована: Фев. 25, 2022
Alzheimer’s
and
Parkinson’s
diseases
are
the
two
most
common
forms
of
neurodegenerative
diseases.
The
exact
etiology
these
disorders
is
not
well
known;
however,
environmental,
molecular,
genetic
influences
play
a
major
role
in
pathogenesis
Using
disease
(AD)
as
archetype,
pathological
findings
include
aggregation
Amyloid
Beta
(Aβ)
peptides,
mitochondrial
dysfunction,
synaptic
degradation
caused
by
inflammation,
elevated
reactive
oxygen
species
(ROS),
cerebrovascular
dysregulation.
This
review
highlights
neuroinflammatory
neuroprotective
epigallocatechin-3-gallate
(EGCG):
medicinal
component
green
tea,
known
nutraceutical
that
has
shown
promise
modulating
AD
progression
due
to
its
antioxidant,
anti-inflammatory,
anti-aging
abilities.
report
also
re-examines
current
literature
provides
innovative
approaches
for
EGCG
be
used
preventive
measure
alleviate
other
disorders.
Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(4), С. 1630 - 1630
Опубликована: Фев. 17, 2023
Due
to
the
key
role
of
tumor
necrosis
factor-alpha
(TNF-α)
in
pathogenesis
immunoinflammatory
diseases,
TNF-α
inhibitors
have
been
successfully
developed
and
used
clinical
treatment
autoimmune
disorders.
Currently,
five
anti-TNF-α
drugs
approved:
infliximab,
adalimumab,
golimumab,
certolizumab
pegol
etanercept.
Anti-TNF-α
biosimilars
are
also
available
for
use.
Here,
we
will
review
historical
development
as
well
present
potential
future
applications
therapies,
which
led
major
improvements
patients
with
several
such
rheumatoid
arthritis
(RA),
ankylosing
spondylitis
(AS),
Crohn’s
disease
(CD),
ulcerative
colitis
(UC),
psoriasis
(PS)
chronic
endogenous
uveitis.
Other
therapeutic
areas
under
evaluation,
including
viral
infections,
e.g.,
COVID-19,
neuropsychiatric
disorders
certain
forms
cancer.
The
search
biomarkers
able
predict
responsiveness
is
discussed.
Abstract
Cerebrovascular
disease
underpins
vascular
dementia
(VaD),
but
structural
and
functional
changes
to
the
cerebral
vasculature
contribute
pathology
cognitive
decline
in
Alzheimer's
(AD).
In
this
review,
we
discuss
contribution
of
amyloid
angiopathy
non‐amyloid
small
vessel
AD,
accompanying
density,
maintenance
remodelling
vessels
(including
alterations
composition
function
cerebrovascular
basement
membrane).
We
consider
how
abnormalities
constituent
cells
neurovascular
unit
–
particularly
endothelial
pericytes
impairment
blood‐brain
barrier
(BBB)
impact
on
pathogenesis
AD.
also
are
likely
impair
Aβ
clearance
both
intra‐periarteriolar
drainage
(IPAD)
transport
peptides
across
BBB,
impaired
coupling
reduced
blood
flow
relation
metabolic
demand
increase
amyloidogenic
processing
APP
production
Aβ.
review
vasoactive
properties
themselves,
probable
bi‐directional
relationship
between
dysfunction
accumulation
Lastly,
recent
methodological
advances
transcriptomics
imaging
that
have
provided
novel
insights
into
assessment
retina
allow
vivo
detection
early
stages
Abstract
There
are
several
hypotheses
concerning
the
underlying
pathophysiological
mechanisms
of
major
depression,
which
centre
largely
around
adaptive
changes
in
neuronal
transmission
and
plasticity,
neurogenesis,
circuit
regional
connectivity.
The
immune
endocrine
systems
commonly
implicated
driving
these
changes.
An
intricate
interaction
stress
hormones,
innate
cells
actions
soluble
mediators
immunity
within
nervous
system
is
described
as
being
associated
with
symptoms
depression.
Bridging
processes
to
neurotransmission
signalling
key
cortical
limbic
brain
circuits
critical
understanding
depression
a
disorder
neuroimmune
origins.
Emergent
areas
research
include
growing
recognition
system,
advances
neuroimaging
techniques
mechanistic
insights
gained
from
transgenic
animals.
Elucidation
glial–neuronal
interactions
providing
additional
avenues
into
promising
research,
development
clinically
relevant
disease
models
discovery
novel
therapies.
This
narrative
review
focuses
on
molecular
cellular
that
influenced
by
inflammation
stress.
aim
this
provide
an
overview
our
current
origin,
focusing
neuroendocrine
dysregulation
pathophysiology.
Advances
lie
pursuit
biomarkers,
potential
biomarker
signatures
improve
clinical
outcomes
yet
be
fully
realised.
Further
investigations
expand
panels
including
integration
neuroimaging,
utilising
individual
stratify
patients
more
homogenous
subpopulations
targeting
for
new
treatment
approaches
will
help
address
unmet
need.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(11), С. 5803 - 5803
Опубликована: Май 26, 2024
The
neuroimmune
system
is
a
collection
of
immune
cells,
cytokines,
and
the
glymphatic
that
plays
pivotal
role
in
pathogenesis
progression
Alzheimer’s
disease
(AD).
Of
particular
focus
are
group
signaling
molecules
facilitate
communication
among
cells
contribute
to
inflammation
AD.
Extensive
research
has
shown
dysregulated
secretion
certain
cytokines
(IL-1β,
IL-17,
IL-12,
IL-23,
IL-6,
TNF-α)
promotes
neuroinflammation
exacerbates
neuronal
damage
However,
anti-inflammatory
(IL-2,
IL-3,
IL-33,
IL-35)
also
secreted
during
AD
onset
progression,
thereby
preventing
neuroinflammation.
This
review
summarizes
involvement
pro-
pathology
discusses
their
therapeutic
potential.
Theranostics,
Год журнала:
2021,
Номер
11(19), С. 9452 - 9469
Опубликована: Янв. 1, 2021
Background:
Neuronal
death
is
a
major
hallmark
of
Alzheimer's
disease
(AD).
Necroptosis,
as
programmed
necrotic
process,
activated
in
AD.
However,
what
signals
and
factors
initiate
necroptosis
AD
largely
unknown.
Methods:
We
examined
the
expression
levels
critical
molecules
necroptotic
signaling
pathway
by
immunohistochemistry
(IHC)
staining
immunoblotting
using
brain
tissues
from
patients
mouse
models
APP/PS1
5×FAD.
performed
stereotaxic
injection
with
recombinant
TNF-α,
anti-TNFR1
neutralizing
antibody
or
AAV-mediated
gene
knockdown
mice.
For
vitro
studies,
we
used
TNF-α
combined
zVAD-fmk
Smac
mimetic
to
establish
neuronal
utilized
pharmacological
molecular
biological
approaches
study
pathways.
Results:
find
that
dependent
on
upstream
TNF-α/TNFR1
both
cell
cultures
models.
Upon
stimulation,
accumulated
p62
recruits
RIPK1
induces
its
self-oligomerization,
activates
downstream
RIPK1/RIPK3/MLKL
cascade,
leading
necroptosis.
Ectopic
accumulation
caused
impaired
autophagy
flux,
which
mediated
UVRAG
downregulation
during
TNF-α-promoted
Notably,
overexpression
inhibits
Conclusions:
identify
finely
controlled
regulation
coordinated
signaling,
RIPK1/3
activity
machinery.
Strategies
could
fine-tune
may
bring
promising
therapeutics
for
Antioxidants,
Год журнала:
2022,
Номер
11(5), С. 923 - 923
Опубликована: Май 8, 2022
The
heme
oxygenase
(HO)
system
is
believed
to
be
a
crucial
mechanism
for
the
nervous
under
stress
conditions.
HO
degrades
carbon
monoxide,
iron,
and
biliverdin.
These
degradation
products
are
involved
in
modulating
cellular
redox
homeostasis.
first
identified
isoform
of
system,
HO-1,
an
inducible
protein
that
highly
expressed
peripheral
organs
barely
detectable
brain
normal
conditions,
whereas
HO-2
constitutive
brain.
Several
lines
evidence
indicate
HO-1
dysregulation
associated
with
inflammation
neurodegeneration,
including
Parkinson’s
Alzheimer’s
diseases.
In
this
review,
we
summarize
essential
roles
plays
ensuring
health
molecular
through
which
dysfunction
leads
neurodegenerative
diseases
disruption
We
also
provide
summary
herbal
medicines
regulation
expression
explore
current
situation
regarding
remedies
disorders.
Current Research in Pharmacology and Drug Discovery,
Год журнала:
2022,
Номер
4, С. 100149 - 100149
Опубликована: Дек. 20, 2022
Neurodegeneration
and
synaptic
loss
in
Alzheimer's
disease
(AD)
lead
to
impairment
memory
functions.
Neuroinflammation
causes
activation
of
microglia
astrocytes
cells
that
locally
systemically
produces
inflammatory
cytokines
which
can
serve
as
early
diagnostic
markers
or
therapeutic
targets
AD.
Pro-inflammatory
(Interleukins
(IL-1β,
IL-6
IL-10)
tumor
necrosis
factor
(TNF
α))
levels
were
estimated
serum,
cerebral
tissue,
hepatic
renal
tissue
treatment
groups
scopolamine-induced
amnesia
mice
model
using
ELISA
protocol.
The
results
showed
AD
exhibited
elevated
IL1β,
IL6,
IL10
TNFα
indicate
contribution
pro-inflammatory
the
progression
A
significant
reduction
concentration
IL-10
TNF-α
noticed
animal
group
treated
with
marketed
memantine
tablet
(Admenta),
pure
drug
(MEMp),
memantine-poly
(lactic-co-glycolic
acid)
self-assembled
nanoscaffolds
(MEM-PLGA)
SANs,
Polyethylene
Glycol
coated
[(PEG-MEM-PLGA)
SANs]
[(lactic-co-glycolic
acid)]
grafted
Bone
Marrow
Derived
Stem
Cell
((PEG-MEM-PLGA)
SANs-BMSc),
whereas
a
high
level
was
observed
tissues
normal
induced
emerging
potential
trigger
either
neurons
survival
after
injury
causing
neurodegeneration
cell
apoptosis.
Neuroregenerative
stem
helps
proliferation
neuronal
thus
improves
cognition
model.